PMC:7405836 / 98994-99272 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T344","span":{"begin":139,"end":145},"obj":"Body_part"}],"attributes":[{"id":"A344","pred":"fma_id","subj":"T344","obj":"http://purl.org/sig/ont/fma/fma62970"}],"text":"Effective drugs to manage COVID-19 patients include remdesivir, lopinavir/ritonavir alone or in a blend with interferon beta, convalescent plasma, and monoclonal antibodies (MAbs); however, efficacy and safety issues of these drugs require additional clinical trials (187, 281)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T899","span":{"begin":26,"end":34},"obj":"Disease"}],"attributes":[{"id":"A899","pred":"mondo_id","subj":"T899","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Effective drugs to manage COVID-19 patients include remdesivir, lopinavir/ritonavir alone or in a blend with interferon beta, convalescent plasma, and monoclonal antibodies (MAbs); however, efficacy and safety issues of these drugs require additional clinical trials (187, 281)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T893","span":{"begin":96,"end":97},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T894","span":{"begin":139,"end":145},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"}],"text":"Effective drugs to manage COVID-19 patients include remdesivir, lopinavir/ritonavir alone or in a blend with interferon beta, convalescent plasma, and monoclonal antibodies (MAbs); however, efficacy and safety issues of these drugs require additional clinical trials (187, 281)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T28551","span":{"begin":10,"end":15},"obj":"Chemical"},{"id":"T60290","span":{"begin":52,"end":62},"obj":"Chemical"},{"id":"T53613","span":{"begin":64,"end":83},"obj":"Chemical"},{"id":"T96726","span":{"begin":64,"end":73},"obj":"Chemical"},{"id":"T69274","span":{"begin":74,"end":83},"obj":"Chemical"},{"id":"T73731","span":{"begin":109,"end":119},"obj":"Chemical"},{"id":"T72220","span":{"begin":120,"end":124},"obj":"Chemical"},{"id":"T50578","span":{"begin":226,"end":231},"obj":"Chemical"}],"attributes":[{"id":"A11793","pred":"chebi_id","subj":"T28551","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A82295","pred":"chebi_id","subj":"T60290","obj":"http://purl.obolibrary.org/obo/CHEBI_145994"},{"id":"A431","pred":"chebi_id","subj":"T53613","obj":"http://purl.obolibrary.org/obo/CHEBI_145924"},{"id":"A61544","pred":"chebi_id","subj":"T96726","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"},{"id":"A78579","pred":"chebi_id","subj":"T69274","obj":"http://purl.obolibrary.org/obo/CHEBI_45409"},{"id":"A17760","pred":"chebi_id","subj":"T73731","obj":"http://purl.obolibrary.org/obo/CHEBI_52999"},{"id":"A56470","pred":"chebi_id","subj":"T72220","obj":"http://purl.obolibrary.org/obo/CHEBI_10545"},{"id":"A59563","pred":"chebi_id","subj":"T50578","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"Effective drugs to manage COVID-19 patients include remdesivir, lopinavir/ritonavir alone or in a blend with interferon beta, convalescent plasma, and monoclonal antibodies (MAbs); however, efficacy and safety issues of these drugs require additional clinical trials (187, 281)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T686","span":{"begin":0,"end":278},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Effective drugs to manage COVID-19 patients include remdesivir, lopinavir/ritonavir alone or in a blend with interferon beta, convalescent plasma, and monoclonal antibodies (MAbs); however, efficacy and safety issues of these drugs require additional clinical trials (187, 281)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"2658","span":{"begin":109,"end":124},"obj":"Gene"},{"id":"2660","span":{"begin":35,"end":43},"obj":"Species"},{"id":"2663","span":{"begin":52,"end":62},"obj":"Chemical"},{"id":"2664","span":{"begin":64,"end":83},"obj":"Chemical"},{"id":"2671","span":{"begin":26,"end":34},"obj":"Disease"}],"attributes":[{"id":"A2658","pred":"tao:has_database_id","subj":"2658","obj":"Gene:3456"},{"id":"A2660","pred":"tao:has_database_id","subj":"2660","obj":"Tax:9606"},{"id":"A2663","pred":"tao:has_database_id","subj":"2663","obj":"MESH:C000606551"},{"id":"A2664","pred":"tao:has_database_id","subj":"2664","obj":"MESH:C558899"},{"id":"A2671","pred":"tao:has_database_id","subj":"2671","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Effective drugs to manage COVID-19 patients include remdesivir, lopinavir/ritonavir alone or in a blend with interferon beta, convalescent plasma, and monoclonal antibodies (MAbs); however, efficacy and safety issues of these drugs require additional clinical trials (187, 281)."}